Financial Performance - Q3 2025 revenue reached ¥393,790,760, a 4.23% increase compared to the same period last year[5] - Net profit attributable to shareholders was ¥46,193,818, reflecting a 2.63% year-over-year growth[5] - Basic earnings per share increased by 2.94% to ¥0.35[5] - Total operating revenue for Q3 2025 reached ¥1,176,255,918.15, an increase of 2.9% compared to ¥1,147,210,821.13 in the same period last year[18] - Net profit for the period was ¥142,624,680.23, representing a growth of 8.5% from ¥131,409,200.64 in the previous year[19] - The total comprehensive income attributable to the parent company was CNY 124,880,364.68, an increase from CNY 114,196,777.29 in the previous period, representing a growth of approximately 5.8%[20] - Basic and diluted earnings per share increased to CNY 0.94 from CNY 0.86, reflecting a growth of 9.3%[20] Cash Flow and Investments - Operating cash flow net amount was ¥47,680,182, an 18.00% increase from the previous year[5] - Cash inflow from operating activities totaled CNY 1,124,732,821.37, up from CNY 1,003,771,130.69, indicating an increase of about 12.0%[23] - The net cash flow from operating activities was CNY 47,680,182.42, compared to CNY 40,406,442.14 in the previous period, marking an increase of approximately 17.6%[23] - Net cash flow from investing activities improved by 218.86% to ¥143,642,674.66, primarily due to a decrease in cash paid for investments[11] - Cash inflow from investment activities was CNY 760,340,471.36, slightly down from CNY 760,382,901.92, showing a negligible decrease[23] - The net cash flow from investment activities improved to CNY 143,642,674.66 from a negative CNY 120,854,168.69, indicating a significant turnaround[23] - Cash inflow from financing activities was CNY 154,581,400.00, compared to CNY 82,910,000.00 in the previous period, representing an increase of approximately 86.5%[23] - The net increase in cash and cash equivalents was CNY 190,867,011.41, contrasting with a decrease of CNY 117,521,482.03 in the previous period[23] - The ending balance of cash and cash equivalents was CNY 569,473,874.89, up from CNY 323,569,825.29, reflecting a growth of approximately 76.2%[23] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥3,288,757,008.59, a 3.85% increase from the end of the previous year[5] - The total liabilities increased to ¥1,255,307,247.41 from ¥1,222,888,230.14, reflecting a rise of 2.6%[17] - The company's accounts receivable increased to ¥1,221,351,177.55 from ¥1,040,289,082.85, marking a rise of 17.4%[16] - Total assets reached ¥3,288,757,008.59, up from ¥3,166,693,859.94, indicating a growth of 3.8%[17] - The total equity attributable to shareholders increased to ¥1,931,406,368.34 from ¥1,847,106,552.51, reflecting a growth of 4.5%[17] Shareholder Information - Total number of ordinary shareholders at the end of the reporting period was 13,338, with no preferred shareholders[12] - The largest shareholder, Yu Xiaoxia, holds 20.39% of shares, totaling 27,375,353 shares[12] - The top ten shareholders collectively hold significant stakes, with the largest three individuals holding a combined 51.99%[12] Other Financial Metrics - Cash and cash equivalents increased by 45.90% to ¥592,356,681.29 due to the redemption of financial products[10] - Long-term equity investments rose by 30.91% to ¥61,737,462.38, indicating growth in investment activities[10] - Non-recurring gains and losses for the reporting period totaled ¥918,629.63, primarily from government subsidies and financial products[7] - Deferred revenue increased by 55.63% to ¥7,464,448.18, primarily due to government subsidies related to assets received during the reporting period[11] - Investment income rose by 59.13% to ¥12,441,363.10, attributed to increased returns from joint ventures and associates[11] - Research and development expenses for the period were ¥21,026,241.07, up from ¥16,870,312.99, showing a year-over-year increase of 24.8%[19] - The company reported a significant decrease in asset impairment losses by 98.21%, down to ¥16,538.11 from ¥923,989.26[11] Accounting Standards - The company plans to implement new accounting standards starting January 1, 2024, which will not have a significant impact on financial statements for the reporting period[5] Audit Information - The company did not undergo an audit for the third quarter financial report[24]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001230 证券简称：劲旅环境 公告编号：2025-059 劲旅环境科技股份有限公司 关于召开2025年第三季度业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 为便于广大投资者更加深入地了解公司经营情况，公司定于2025年11月03日（星期一）召开2025年第三 季度业绩说明会。现将本次业绩说明会的相关内容公告如下： 3、邮箱地址：securities@jlhoe.com 二、投资者参会方式 本次业绩说明会在进门财经平台以网络会议方式举行，投资者可通过以下方式参与。 1、电脑端：点击链接https://s.comein.cn/9pkn8e4a，进入页面，按指引申请参会。 ■ （业绩说明会入口专用二维码） 三、咨询方式 1、咨询机构：董事会办公室 2、咨询电话：0551-64282862 一、业绩说明会安排 欢迎广大投资者参与本次业绩说明会。在此，公司对长期以来关心和支持公司发展并积极提出建议的投 资者表示衷心感谢！ 特此公告。 劲旅环境科技股份有限公司 董事会 2025年10月28 ...

证券代码：001230 证券简称：劲旅环境 公告编号：2025-059 劲旅环境科技股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 为便于广大投资者更加深入地了解公司经营情况，公司定于 2025 年 11 月 03 日（星期一）召开 2025 年第三季度业绩说明会。现将本次业绩说明会的相关 内容公告如下： 2、会议召开方式：网络会议 3、召开平台：进门财经平台 4、本次出席人员：总经理王颖哲先生；董事会秘书杨晶晶女士；财务总监 宣迎东先生。 二、投资者参会方式 本次业绩说明会在进门财经平台以网络会议方式举行，投资者可通过以下方 式参与。 1、电脑端：点击链接 https://s.comein.cn/9pkn8e4a，进入页面，按指引申请 参会。 2、手机端：通过"进门"APP，搜索"001230""劲旅环境"，进入"劲 旅环境 2025 年第三季度业绩说明会"，或扫描下方二维码参会： （业绩说明会入口专用二维码） 一、业绩说明会安排 1、会议召开时间：2025 年 11 月 03 日 15:00-1 ...

Core Insights - Changchun Jingly Environmental Technology Co., Ltd. has been established with a registered capital of 30 million yuan, focusing on various services including AI application system integration, information system maintenance, IoT device sales, and cloud-based business outsourcing [1][2]. Company Information - The company is a limited liability company with a legal representative named Chen Lang and is currently in operation [2]. - The registered address is located in the Changchun Comprehensive Bonded Zone, Jilin Province [2]. - The company is co-owned by Jingly Environment (001230) and other stakeholders, with Jingly Environment holding an 80% stake [1][2]. Business Scope - The business scope includes intelligent industry application system integration services, information system operation and maintenance services, IoT device sales, and cloud platform-based business outsourcing services [1][2]. - Additional services encompass technical consulting, environmental protection equipment manufacturing and sales, and various waste management services [2].

Core Insights - Baiyang Pharmaceutical has signed a strategic cooperation agreement with Peking University International Hospital to establish a precision radiotherapy center focused on brain tumors [1][3] - The ZAP-X device, operated by Baiyang, is designed to enhance the precision and safety of brain tumor radiotherapy, addressing the increasing incidence of brain metastases in China, which exceeds 1.5 million new cases annually [3] Group 1 - The collaboration aims to create a high-level radiotherapy platform that specializes in the treatment of brain tumors [1][3] - The ZAP-X device features an innovative dual-rotating spherical structure that allows X-rays to target tumors from thousands of non-coplanar angles, concentrating radiation on the tumor while minimizing exposure to surrounding healthy tissue [3] - ZAP-X has received regulatory approval in 24 countries and regions worldwide, with over 5,000 clinical treatments completed to date [3] Group 2 - Baiyang's chairman, Fu Gang, emphasized that this partnership is a significant step towards enhancing the clinical application of advanced radiotherapy equipment and improving access to quality medical resources [3]

Core Viewpoint - The company has announced its 2025 interim dividend plan, proposing a cash dividend of RMB 1.10 per 10 shares (including tax), with a total cash dividend amounting to RMB 14,764,866.27 (including tax) based on the total share capital of 134,226,057 shares [2][3][4]. Dividend Distribution Plan - The dividend distribution is based on the total share capital of 134,226,057 shares, with no shares excluded from the dividend distribution [2][4]. - The cash dividend per share, calculated based on the total share capital, is RMB 0.11 per share [3]. - The total cash dividend is set at RMB 14,764,866.27, which represents 18.52% of the net profit attributable to shareholders for the first half of 2025 [4]. Key Dates - The record date for the dividend distribution is October 23, 2025, and the ex-dividend date is October 24, 2025 [8][9]. Dividend Payment Method - The cash dividends will be directly credited to the shareholders' accounts through their custodial securities companies on the ex-dividend date [11]. - The company will bear all legal responsibilities for any discrepancies in dividend payments due to changes in shareholders' accounts during the application period [12]. Shareholder Eligibility - The dividend distribution is applicable to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, as of the record date [10]. Stock Incentive Plan - The company has approved a stock incentive plan, granting 1,730,000 restricted stocks to 22 eligible participants at a price of RMB 11.18 per share, which will increase the total share capital to 134,226,057 shares [5][6].

（文章来源：证券日报） 证券日报网讯 10月16日晚间，劲旅环境发布公告称，2025年半年度权益分派方案为向全体股东每10股 派1.1元人民币现金（含税）。股权登记日为2025年10月23日，除权除息日为2025年10月24日。 ...

3．股权登记日：2025 年 10 月 23 日；除权除息日为：2025 年 10 月 24 日 证券代码：001230 证券简称：劲旅环境 公告编号：2025-058 劲旅环境科技股份有限公司 2025年半年度权益分派实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1．分红年度：2025 年半年度 2．分配方案：分配比例固定 1．2025 年 5 月 15 日，公司召开 2024 年年度股东大会，审议通过了《关于 提请股东大会授权董事会制定 2025 年中期分红方案的议案》，同意授权董事会 制定 2025 年中期分红方案，分红条件为公司在当期盈利、累计未分配利润为正； 公司现金流可以满足正常经营和持续发展的要求。在满足前述分红条件下，分红 金额不超过当期归属于上市公司股东的净利润。本次股东大会决议公告已于 2025 年 5 月 16 日刊登在《证券时报》《中国证券报》《上海证券报》《证券日 报》《经济参考报》和巨潮资讯网（www.cninfo.com.cn）上。 2．2025 年 8 月 25 日，公司召开第二届董事会第二十二次会议，以 ...

Core Points - The company has completed the registration of the 2025 Restricted Stock Incentive Plan, granting a total of up to 1.73 million shares to 22 incentive objects at a price of 11.18 yuan per share [1][4][5] Group 1: Incentive Plan Details - The total number of restricted shares granted is 1,000,040 shares, accounting for 0.75% of the company's total share capital before the grant [3][7] - The source of the restricted shares is from the company's repurchased shares [7][16] - The effective period of the incentive plan is from the grant date until the shares are released from restrictions or canceled, lasting no more than 48 months [8][9] Group 2: Approval Process - The plan underwent several approval processes, including meetings of the board of directors and the supervisory board, which confirmed compliance with relevant regulations [2][4] - The plan was publicly announced, and no objections were raised during the public notice period [2][4] Group 3: Performance Assessment - The assessment period for the incentive plan is from 2025 to 2027, with annual evaluations based on specific performance indicators [14] - The performance targets include revenue and net profit, with the achievement of any one target allowing for the release of shares from restrictions [14][24] Group 4: Financial Impact - The total cost of the granted restricted shares is estimated at 20.69 million yuan, which will be recognized as an expense over the relevant years based on the release of restrictions [23][24] - The incentive plan is expected to enhance company performance, outweighing the costs associated with the stock grants [24]

Core Viewpoint - The implementation of equity incentives has significantly boosted the performance of many companies in the A-share market, with an average increase of over 64% in the equity incentive sector, outperforming major indices like the Shanghai Composite Index and the ChiNext Index [1][2]. Group 1: Performance of Companies - The equity incentive sector has seen 27 stocks more than double in value this year, with New Yisheng leading at a 354.85% increase [1]. - Companies like Nanya New Materials and Zhongji Xuchuang have also shown impressive growth, with revenue increases of over 43% and net profit increases of nearly 58% [1]. - The majority of companies that implemented equity incentives have experienced significant performance improvements, with 88% reporting revenue growth and 76.88% reporting net profit growth [2]. Group 2: Impact of Equity Incentives - Equity incentives align the interests of employees with those of the company, enhancing motivation and innovation, which in turn drives company performance in various areas [2]. - The market perceives companies that implement equity incentives as more confident in their future growth, leading to higher stock valuations [2]. Group 3: Future Growth Potential - Recent data indicates that 63 stocks have implemented equity incentives since September, with many expected to achieve high growth rates in net profit, exceeding 15% in the coming years [3]. - Shaoneng Co., with a low price-to-book ratio of 1.32, is highlighted as a company with significant growth potential in the clean energy sector [3]. - The company has set ambitious performance targets for its equity incentive plan, aiming for a net profit growth rate of at least 30% in 2025 and 97% by 2027 [4][5]. Group 4: Market Trends - The slow bull market in A-shares is creating favorable conditions for investment in the equity incentive sector, with expectations of more quality companies emerging [6]. - The increasing recognition of the importance of equity incentives among companies is likely to lead to more opportunities for investors [6].